To investigate glycemic and insulinemic index of teff bread relative to wheat bread in healthy individuals.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
glucose en insuline respons op eten
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameters will be glycemic and insulinemic index, calculated
from two-hour postprandial plasma glucose and serum insulin levels.
Secondary outcome
not applicable
Background summary
No scientific evidence is available regarding the glucose and insulin response
of food products containing Eragrostis Tef (teff).
Study objective
To investigate glycemic and insulinemic index of teff bread relative to wheat
bread in healthy individuals.
Study design
Three test foods and a control food will be consumed in a randomized crossover
trial. The foods will be offered to each subject during five separate test
days. Two-hour postprandial glucose and insulin will be measured.
Intervention
Per test day, subjects will receive a portion equivalent to 50 g of available
carbohydrate, which they ingest within 10 -15 minutes. At 0, 15, 30, 45, 60, 90
and 120 minutes blood samples will be taken. The test foods are breads baked
with different types of flour/meal developed by *Koopmans meel
b.v.* (Leeuwarden). All ingredients of the products are suitable for human
consumption and are microbiologically safe. The wheat flour will be exchanged
for teff meal in 2 different dosages and for wheat meal. At the first and the
last measuring day white bread will be served as the control food. The other 3
days, 3 test foods will be served in a randomized order.
Study burden and risks
The intervention is non-therapeutic to the participant. The risk associated
with participation is negligible and the burden can be considered as low.
Subjects have to come to the research centre once for a screening visit during
which several questionnaires are filled out and anthropometrics are measured.
Then subjects have to come to the research centre 5 times for approximately 3
hours, during which a venous cannula is placed by an experienced research nurse
and 7 blood samples are taken after ingestion of bread. All test foods are
based on commercially available products and are safe to use for human
consumption.
Agora 1
8934 AK Leeuwarden
Nederland
Agora 1
8934 AK Leeuwarden
Nederland
Listed location countries
Age
Inclusion criteria
Age: 18-50 year
BMI: 18-25 kg/m2
Healthy: as judged by the participant
Exclusion criteria
Diabetes, or any endocrine disorder
Hypersensitivity for gluten or bread products
Weight loss or weight gain of more than 5 kg during the last 2 months
Using an energy restricted diet during the last 2 months
Lack of appetite for any (unknown) reason
Previous problems with blood sampling (veins, fainting)
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL26033.081.08 |